Global dementia diagnoses are steeply increasing. While advances in neuroimaging, neuropathology, and genetics research have improved our understanding of neurodegenerative diseases causing dementia, precise antemortem diagnosis, as well as sensitive and specific biomarkers that can facilitate a differential diagnosis and aid in participant recruitment in clinical trials, remains elusive. The...